HB 966 bars the Secretary of Veterans Affairs from denying a veteran benefits solely because the veteran participates in a state-approved marijuana program. It also requires VA clinicians to discuss marijuana use with enrolled veterans, adjust treatment plans accordingly, and record such use in veterans’ medical records.
Additionally, the bill authorizes VA providers to offer recommendations and opinions about veterans’ participation in state cannabis programs. The definition elements clarify what counts as marijuana and what counts as a state for purposes of the act.
This is a policy move aimed at aligning veterans’ healthcare with state cannabis realities and ensuring benefit eligibility is not automatically jeopardized by state-legal use.
At a Glance
What It Does
The act prevents denial of VA-administered benefits solely due to participation in a state-approved marijuana program. It also requires VA clinicians to discuss cannabis use and adjust care, and to document usage in medical records; it authorizes providers to give recommendations regarding participation in state programs.
Who It Affects
Veterans enrolled in VA care who participate in state-approved cannabis programs; Veterans Health Administration clinicians and staff; VA benefits administrators.
Why It Matters
It signals federal tolerance for state-legal cannabis participation within VA care, codifies treatment discussions, and seeks to prevent benefit denial based on cannabis use, potentially reshaping care and eligibility dynamics for veterans.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Section 1 names the act the Veterans Cannabis Use for Safe Healing Act. It sets the stage for how the Department of Veterans Affairs interacts with veterans who participate in state-approved cannabis programs.
The key substantive change is in Section 2, which limits the VA’s ability to deny benefits to veterans simply because they have participated in a state-legal cannabis program. The bill directs VA health care to engage with veterans about marijuana use and to incorporate that information into care plans.
Specifically, physicians and other health care providers within the Veterans Health Administration must discuss use with the veteran, adjust treatment plans accordingly, and record the use in the veteran’s medical records. It also authorizes VA providers to offer recommendations or opinions to veterans about participating in state cannabis programs, where allowed by law.
The definitions tie “marijuana” to the Controlled Substances Act and define “State” consistently with existing VA code, anchoring the policy in current federal language. Taken together, the bill attempts to harmonize veteran care with state cannabis programs while preserving the federal framework.”
The Five Things You Need to Know
Section 2(a) prohibits denial of benefits solely for cannabis participation.
Section 2(b) requires VA clinicians to discuss marijuana use and adjust treatment plans.
Section 2(b)(2) requires recording marijuana use in the veteran’s medical records.
Section 2(c) authorizes VA providers to give recommendations about participation in state programs.
Definitions tie 'marijuana' to the CSA and 'State' to title 38 provisions.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Section 1 designates the act as the Veterans Cannabis Use for Safe Healing Act. This anchors the framework and signals how the law should be cited in VA settings.
Veteran participation in state-approved marijuana programs
Section 2 establishes the core protections and obligations. Subsection (a) bars denial of any VA-administered benefit based solely on participation in a state-approved cannabis program. Subsection (b) mandates that VA clinicians discuss marijuana use with veterans in the system of patient enrollment and adjust medical treatment plans accordingly, while recording such use in the veteran’s medical records. Subsection (c) authorizes physicians and other VA providers to offer recommendations and opinions regarding participation in state programs. Subsection (d) defines “marijuana” and “State” for purposes of the act, aligning terminology with the CSA and Title 38 definitions.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Veterans enrolled in VA care who participate in state-approved marijuana programs, as benefits cannot be denied on the basis of cannabis participation.
- VA physicians and other health care providers, who must discuss use and adjust treatment plans within the medical record.
- VA benefits administrators and adjudicators, who gain clearer guidance on benefit eligibility related to state-legal cannabis participation.
- Advocacy groups and researchers focused on veterans’ health and policy clarity, who benefit from a more predictable VA framework.
Who Bears the Cost
- Potential training and workflow changes for VA clinicians to incorporate cannabis discussions and documentation.
- Increased administrative requirements for medical record-keeping related to cannabis use.
- Possible privacy and data-management considerations given heightened documentation of cannabis use in VA records.
- Resource constraints within the VA system to implement, monitor, and enforce the new requirements.
Key Issues
The Core Tension
Balancing veterans’ access to care and benefits with the ongoing federal prohibition on marijuana — the bill protects benefit eligibility and care integration in practice, but it operates within a federal framework that remains unaffected, creating potential compliance and policy coherence challenges.
The act acknowledges a policy tension between state-legal cannabis programs and federal law, attempting to protect veterans’ benefits while still operating within the current federal framework. It relies on “notwithstanding any other provision of law” language to shield benefit determinations from cannabis participation in the eyes of the VA, yet it does not change federal illegality or funding.
The requirement that clinicians discuss use and adjust treatment plans presumes there is clinically relevant influence of cannabis on care, and that such discussions can be integrated into existing records without creating new privacy or interoperability barriers. Finally, the bill does not create funding or explicit implementation timelines, leaving actual compliance arrangements to VA administration and budget processes.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.